Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

By Application

Infectious Disease

Creative Biolabs is a pioneer of recombinant antibody and manufacture, providing the most comprehensive list of recombinant antibody products in the world.

Infectious diseases are caused by tiny microorganisms such as bacteria, viruses, fungi, and parasites. Antigens are carried on the cell surface of all infectious organisms. The human immune system recognizes and eliminates these pathogens. In response to those foreign invaders, proteins called antibodies are formed to destroy or control them. An antibody is specific for an antigen. Thus, each one can be used to detect the presence of the other. Several different techniques may be employed, such as precipitation reaction, agglutination reaction, complement fixation, immunofluorescent assay and ELISA.